Approval · Notice of Compliance 11829 · 2010
RAN-NABILONE: Notice of Compliance 11829
Issued November 1, 2010
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 11829
- Date
- November 1, 2010
- Company
- Ranbaxy Pharmaceuticals Canada Inc.Brampton, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- New manufacturer and product name
- Therapeutic class
- Antiemetic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| RAN-NABILONE | 02358077 | Cancelled Post Market |
| RAN-NABILONE | 02358085 | Cancelled Post Market |
| RAN-NABILONE | 02358093 | Cancelled Post Market |